Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Current Opinion in Urology|February 7, 2013
Lessons from in-vivo models of castration-resistant prostate cancerDong Lin, Peter W Gout, Yuzhuo WangJournal of Cellular Physiology|January 9, 2008
The x(c)- cystine/glutamate antiporter: a potential target for therapy of cancer and other diseasesMaisie Lo, Yu-Zhuo Wang, Peter W GoutCurrent Gene Therapy|October 28, 2005
Animal models for growth hormone gene therapyCibele N Peroni, Peter W Gout, Paolo BartoliniAnti-Cancer Drugs|January 25, 2003
In vitro studies on the lymphoma growth-inhibitory activity of sulfasalazinePeter W Gout, Chris R Simms, May C RobertsonFrontiers in Bioscience (Scholar Edition)|December 29, 2015
Elevated XPO6 expression as a potential prognostic biomarker for prostate cancer recurrenceJun Hao, Yan Ting Chiang, Peter W Gout, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 28, 2003
Synthesis and chromatographic purification of recombinant human pituitary hormonesMaria Teresa C P Ribela, Peter W Gout, Paolo BartoliniAsian Journal of Andrology|March 5, 2014
Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identificationYan Ting Chiang, Peter W Gout, Colin C Collins, et al.The Journal of Pathology|June 5, 2013
Cancer-generated lactic acid: a regulatory, immunosuppressive metabolite?Stephen Yiu Chuen Choi, Colin C Collins, Peter W Gout, et al.Differentiation; Research in Biological Diversity|April 5, 2012
Epithelial immune cell-like transition (EIT): a proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancersStephen Yiu Chuen Choi, Peter W Gout, Colin C Collins, et al.Frontiers in Genetics|July 20, 2018
Pre-clinical Models for Malignant Mesothelioma Research: From Chemical-Induced to Patient-Derived Cancer XenograftsNoushin Nabavi, Jingchao Wei, Dong Lin, et al.Pageof 5